HemACTIVE - Hemophilia A Study
HemACTIVE is a global research survey in which Bayer is engaging people living with hemophilia A between the ages of 18-65 years and parents of children ages 2-18 years old living with the disease from North America and Europe. The survey aims to identify how hemophilia A affects the daily lives of persons living with this chronic disease and to better understand the role of treatment. To date, over 300 persons with hemophilia have participated and helped to generate great insights on the impact of hemophilia A on many facets of life, including how they define activity.
Kantar Health, a market research firm specializing in medical research, is currently recruiting people living with hemophilia A to take part in the online survey.
To learn more about the qualifications for the study and to link to the study, please visit Study – Hemophilia A.